AMERICAN WELL CORP-CLASS A (AMWL)
US03044L1052 - Common Stock
Overall AMWL gets a fundamental rating of 3 out of 10. We evaluated AMWL against 40 industry peers in the Health Care Technology industry. AMWL has a great financial health rating, but its profitability evaluates not so good. AMWL has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year AMWL has reported negative net income.
AMWL had a negative operating cash flow in the past year.
AMWL had negative earnings in each of the past 5 years.
In the past 5 years AMWL always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -114.49%, AMWL is not doing good in the industry: 82.05% of the companies in the same industry are doing better.
The Return On Equity of AMWL (-145.44%) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -114.49% | ||
| ROE | -145.44% | ||
| ROIC | N/A |
ROA(3y)-49.63%
ROA(5y)-36.53%
ROE(3y)-61.69%
ROE(5y)-45.68%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 36.58%, AMWL is doing worse than 76.92% of the companies in the same industry.
In the last couple of years the Gross Margin of AMWL has declined.
AMWL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.58% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.75%
GM growth 5Y-5.49%
2. Health
2.1 Basic Checks
AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
AMWL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AMWL has more shares outstanding
AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
AMWL has an Altman-Z score of -3.68. This is a bad value and indicates that AMWL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -3.68, AMWL is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.68 |
ROIC/WACCN/A
WACC10.03%
2.3 Liquidity
A Current Ratio of 4.79 indicates that AMWL has no problem at all paying its short term obligations.
With an excellent Current ratio value of 4.79, AMWL belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
AMWL has a Quick Ratio of 4.72. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.
AMWL has a better Quick ratio (4.72) than 84.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.79 | ||
| Quick Ratio | 4.72 |
3. Growth
3.1 Past
The earnings per share for AMWL have decreased strongly by -24.49% in the last year.
Looking at the last year, AMWL shows a decrease in Revenue. The Revenue has decreased by -6.55% in the last year.
The Revenue has been growing by 17.84% on average over the past years. This is quite good.
EPS 1Y (TTM)-24.49%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q22.73%
Revenue 1Y (TTM)-6.55%
Revenue growth 3Y1.83%
Revenue growth 5Y17.84%
Revenue growth Q2Q-10.8%
3.2 Future
The Earnings Per Share is expected to grow by 21.86% on average over the next years. This is a very strong growth
Based on estimates for the next years, AMWL will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y38.38%
EPS Next 2Y28.01%
EPS Next 3Y21.86%
EPS Next 5YN/A
Revenue Next Year1.29%
Revenue Next 2Y11.67%
Revenue Next 3Y12.28%
Revenue Next 5Y7.12%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for AMWL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AMWL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as AMWL's earnings are expected to grow with 21.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.01%
EPS Next 3Y21.86%
5. Dividend
5.1 Amount
AMWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMERICAN WELL CORP-CLASS A
NYSE:AMWL (4/23/2024, 11:11:56 AM)
0.5651
+0.01 (+2.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap163.46M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -114.49% | ||
| ROE | -145.44% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.58% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.79 | ||
| Quick Ratio | 4.72 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-24.49%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y38.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-6.55%
Revenue growth 3Y1.83%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y